Cite
de Diego-Balaguer R, Schramm C, Rebeix I, et al. COMT Val158Met Polymorphism Modulates Huntington's Disease Progression. PLoS One. 2016;11(9):e0161106doi: 10.1371/journal.pone.0161106.
de Diego-Balaguer, R., Schramm, C., Rebeix, I., Dupoux, E., Durr, A., Brice, A., Charles, P., Cleret de Langavant, L., Youssov, K., Verny, C., Damotte, V., Azulay, J. P., Goizet, C., Simonin, C., Tranchant, C., Maison, P., Rialland, A., Schmitz, D., Jacquemot, C., Fontaine, B., Bachoud-Lévi, A. C. (2016). COMT Val158Met Polymorphism Modulates Huntington's Disease Progression. PloS one, 11(9), e0161106. https://doi.org/10.1371/journal.pone.0161106
de Diego-Balaguer, Ruth, et al. "COMT Val158Met Polymorphism Modulates Huntington's Disease Progression." PloS one vol. 11,9 (2016): e0161106. doi: https://doi.org/10.1371/journal.pone.0161106
de Diego-Balaguer R, Schramm C, Rebeix I, Dupoux E, Durr A, Brice A, Charles P, Cleret de Langavant L, Youssov K, Verny C, Damotte V, Azulay JP, Goizet C, Simonin C, Tranchant C, Maison P, Rialland A, Schmitz D, Jacquemot C, Fontaine B, Bachoud-Lévi AC. COMT Val158Met Polymorphism Modulates Huntington's Disease Progression. PLoS One. 2016 Sep 22;11(9):e0161106. doi: 10.1371/journal.pone.0161106. eCollection 2016. PMID: 27657697; PMCID: PMC5033325.
Copy
Download .nbib